23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Wave Life Sciences Ltd. › 2025-2026

Wave Life Sciences Ltd. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Wave Life Sciences Ltd.’s Form 8-K, filed August 11, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 16Reported items
  • 198Asset managers, any item
  • 3,417Fund votes
  • August 5, 2025Main meeting date

Results at a glance

Meeting of August 5, 2025: 14 items on Wave Life Sciences Ltd.’s Form 8-K, filed August 11, 2025: 5 approved · 9 passed (calculated).

Dissent

Notable dissent: 1 director (14.6% against); 1 equity or compensation plan (18.9% against); 1 other board item (21.8% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Ra Capital Management, L.P. (13D, 16.8%, as of August 11, 2026)

Explore Wave Life Sciences Ltd. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Wave Life Sciences Ltd.

These tallies are Wave Life Sciences Ltd.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed August 11, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Wave Life Sciences Ltd. — official shareholder meeting results, meeting held August 5, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Paul B. Bolno, M.D., MBA 129,131,2011,501,2358,680 --14,529,462 99%Passed (calculated)—
Elect Director: Mark H.N. Corrigan, M.D. 129,548,4431,084,9307,743 --14,529,462 99.2%Passed (calculated)—
Elect Director: Christian Henry 111,549,23019,074,53217,354 --14,529,462 85%Passed (calculated)—
Elect Director: Peter Kolchinsky, Ph.D. 130,188,145444,7238,248 --14,529,462 99.7%Passed (calculated)—
Elect Director: Adrian Rawcliffe 130,337,320285,64718,149 --14,529,462 99.8%Passed (calculated)—
Elect Director: Ken Takanashi 124,467,1676,024,248149,701 --14,529,462 95%Passed (calculated)—
Elect Director: Aik Na Tan 130,362,062269,6979,357 --14,529,462 99.8%Passed (calculated)—
Elect Director: Gregory L. Verdine, Ph.D. 130,098,845521,19821,073 --14,529,462 99.6%Passed (calculated)—
Elect Director: Heidi L. Wagner, J.D. 125,980,1414,281,064379,911 --14,529,462 97%Passed (calculated)—
2. The re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix 144,541,282619,5429,754 --0 99.6%Approved—
3. Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy Statement, with the final vo 130,474,503155,61311,000 --14,529,462 99.9%Approved—
4. The amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast 105,936,04924,647,48557,582 --14,529,462 81%Approved—
5. A general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast 102,173,94028,413,70453,472 --14,529,462 78%Approved—
6. On a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast 129,648,036977,46615,614 --14,529,462 99.3%Approved—

Source: Wave Life Sciences Ltd., Form 8-K, filed with the SEC on August 11, 2025 — read the filing on EDGAR.

How asset managers voted at the Wave Life Sciences Ltd. 2025-2026 meetings

198 asset managers disclosed a vote on at least one Wave Life Sciences Ltd. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Wave Life Sciences Ltd.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

Elect Director: Adrian Rawcliffe

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Meeting held August 5, 2025.

Combines 3 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 130,337,320AGAINST: 285,647

Prior year: 99.7% for (August 6, 2024 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: The election of the nominees for director: Adrian Rawcliffe

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Adrian Rawcliffe”): 130,337,320 for, 285,647 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 28,274,133 for, 437 against, 6,157 abstained.

FOR
FOR: 28,274,133AGAINST: 437ABSTAIN: 6,157
Largest asset managers voting on “The election of the nominees for director: Adrian Rawcliffe” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street296,4590 00For
HUSSMAN INVESTMENT TRUST252,0000 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Aik Na Tan

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Meeting held August 5, 2025.

Combines 3 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 130,362,062AGAINST: 269,697

Prior year: 99.7% for (August 6, 2024 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: The election of the nominees for director: Aik Na Tan

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Aik Na Tan”): 130,362,062 for, 269,697 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 28,274,570 for, 6,157 abstained.

FOR
FOR: 28,274,570ABSTAIN: 6,157
Largest asset managers voting on “The election of the nominees for director: Aik Na Tan” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street296,4590 00For
HUSSMAN INVESTMENT TRUST252,0000 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Christian Henry

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Meeting held August 5, 2025.

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 111,549,230AGAINST: 19,074,532

Prior year: 85.3% for (August 6, 2024 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: The election of the nominees for director: Christian Henry

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Christian Henry”): 111,549,230 for, 19,074,532 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 14,948,481 for, 13,326,089 against, 6,157 abstained.

FORAGAINST
FOR: 14,948,481AGAINST: 13,326,089ABSTAIN: 6,157
Largest asset managers voting on “The election of the nominees for director: Christian Henry” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock05,059,945 00Against
T. Rowe Price3,529,3950 00For
Vanguard03,171,588 00Against
Fidelity2,794,94946,751 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab01,977,032 00Against
Loomis Sayles01,812,031 00Against
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse147,657361,444 00Mixed
JPMorgan324,1420 00For
State Street296,4590 00For
HUSSMAN INVESTMENT TRUST252,0000 00For
Equitable20,377230,218 00Mixed
Global X0246,659 00Against
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC0181,521 00Against
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Gregory L. Verdine, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Meeting held August 5, 2025.

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 130,098,845AGAINST: 521,198

Prior year: 99.2% for (August 6, 2024 meeting) ▲ 0.4 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: The election of the nominees for director: Gregory L. Verdine, Ph.D.

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Gregory L. Verdine, Ph.D.”): 130,098,845 for, 521,198 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 28,245,074 for, 29,496 against, 6,157 abstained.

FOR
FOR: 28,245,074AGAINST: 29,496ABSTAIN: 6,157
Largest asset managers voting on “The election of the nominees for director: Gregory L. Verdine, Ph.D.” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street296,4590 00For
HUSSMAN INVESTMENT TRUST252,0000 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Heidi L. Wagner, J.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Meeting held August 5, 2025.

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 125,980,141AGAINST: 4,281,064

Prior year: 96.6% for (August 6, 2024 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: The election of the nominees for director: Heidi L. Wagner, J.D.

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Heidi L. Wagner, J.D.”): 125,980,141 for, 4,281,064 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 27,284,889 for, 749,681 against, 6,157 abstained.

FOR
FOR: 27,284,889AGAINST: 749,681ABSTAIN: 6,157
Largest asset managers voting on “The election of the nominees for director: Heidi L. Wagner, J.D.” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street0296,459 00Against
Equitable250,5950 00For
Global X0246,659 00Against
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial11,76873,500 00Mixed
Delaware/Macquarie081,955 00Against
John Hancock67,5490 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Ken Takanashi

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Meeting held August 5, 2025.

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 124,467,167AGAINST: 6,024,248

Prior year: 89.5% for (August 6, 2024 meeting) ▲ 5.8 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: The election of the nominees for director: Ken Takanashi

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Ken Takanashi”): 124,467,167 for, 6,024,248 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 23,838,161 for, 4,436,409 against, 6,157 abstained.

FORAGAINST
FOR: 23,838,161AGAINST: 4,436,409ABSTAIN: 6,157
Largest asset managers voting on “The election of the nominees for director: Ken Takanashi” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab01,977,032 00Against
Loomis Sayles01,812,031 00Against
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse147,657361,444 00Mixed
JPMorgan324,1420 00For
State Street296,4590 00For
HUSSMAN INVESTMENT TRUST252,0000 00For
Equitable250,5950 00For
Global X0246,659 00Against
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Mark H.N. Corrigan, M.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Meeting held August 5, 2025.

Combines 4 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 129,548,443AGAINST: 1,084,930

Prior year: 99.5% for (August 6, 2024 meeting) ▼ 0.3 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: The election of the nominees for director: Mark H. N. Corrigan, M.D.

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Mark H.N. Corrigan, M.D.”): 129,548,443 for, 1,084,930 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 28,274,133 for, 437 against, 6,157 abstained.

FOR
FOR: 28,274,133AGAINST: 437ABSTAIN: 6,157
Largest asset managers voting on “The election of the nominees for director: Mark H. N. Corrigan, M.D.” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street296,4590 00For
HUSSMAN INVESTMENT TRUST252,0000 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Paul B. Bolno, M.D., MBA

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Meeting held August 5, 2025.

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 129,131,201AGAINST: 1,501,235

Prior year: 99.7% for (August 6, 2024 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: The election of the nominees for director: Paul B. Bolno, M.D., MBA

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Paul B. Bolno, M.D., MBA”): 129,131,201 for, 1,501,235 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 28,274,570 for, 6,157 abstained.

FOR
FOR: 28,274,570ABSTAIN: 6,157
Largest asset managers voting on “The election of the nominees for director: Paul B. Bolno, M.D., MBA” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street296,4590 00For
HUSSMAN INVESTMENT TRUST252,0000 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Peter Kolchinsky, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Meeting held August 5, 2025.

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 130,188,145AGAINST: 444,723

Prior year: 99.7% for (August 6, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: The election of the nominees for director: Peter Kolchinsky, Ph.D.

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Peter Kolchinsky, Ph.D.”): 130,188,145 for, 444,723 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 28,274,570 for, 6,157 abstained.

FOR
FOR: 28,274,570ABSTAIN: 6,157
Largest asset managers voting on “The election of the nominees for director: Peter Kolchinsky, Ph.D.” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street296,4590 00For
HUSSMAN INVESTMENT TRUST252,0000 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by…

No official resultsEXTRAORDINARY TRANSACTIONS

Meeting held June 22, 2026; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 58 asset managers

Description as filed by funds: To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave- Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave- Singapore's notice of, and proxy statement relating to, the Special Meeting of Wave-Singapore shareholders.

The 58 asset managers below reported 37,821,859 for, 16,522 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 37,821,859ABSTAIN: 16,522
Largest asset managers voting on “To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limit” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock6,970,0780 00For
T. Rowe Price6,239,9070 00For
Fidelity6,072,6740 00For
Federated Hermes3,956,2510 00For
PRIMECAP Odyssey Funds3,839,7080 00For
Vanguard2,800,7960 00For
Charles Schwab1,179,4380 00For
DRIEHAUS MUTUAL FUNDS954,0040 00For
State Street648,6610 00For
RBB FUND, INC.575,2150 00For
TIAA506,9400 00For
Bridge Builder Trust437,8810 00For
Equitable334,2790 00For
Dimensional321,4120 00For
Principal313,0730 00For
QUANTITATIVE MASTER SERIES LLC227,0830 00For
Brighthouse215,2740 00For
TRUST FOR PROFESSIONAL MANAGERS201,2590 00For
Prudential/PGIM191,7840 00For
JPMorgan178,6820 00For
Jackson National163,7670 00For
Global X120,9360 00For
Invesco116,2700 00For
Nuveen110,9290 00For
Transamerica110,8240 00For

Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).

A general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the…

Official resultOTHERReported outcome: Approved

Meeting held August 5, 2025.

78% Approved · of votes cast

FOR 78%AGAINST
FOR: 102,173,940AGAINST: 28,413,704
Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.

Wave Life Sciences Ltd.’s own tally for this item (“5. A general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast”): 102,173,940 for, 28,413,704 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5 - Shareholders approved a general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:”
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Wave Life Sciences Ltd.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Approve Issuance of Shares without Preemptive Rights” (3 managers, 396,729 for).

The 55 asset managers below reported 25,699,836 for, 1,927,343 against, 16,819 abstained.

FOR
FOR: 25,699,836AGAINST: 1,927,343ABSTAIN: 16,819
Largest asset managers voting on “To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock4,555,850504,095 00Mixed
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,393,1547,841 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse415,14433,138 00Mixed
State Street0296,459 00Against
Equitable191,21559,380 00Mixed
Global X246,6590 00For
TIAA0218,371 00Against
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST0186,213 00Against
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica0110,769 00Against
Delaware/Macquarie081,955 00Against
Lincoln Financial073,500 00Against
John Hancock28,86838,681 00Mixed
GuideStone066,693 00Against

Showing the 25 largest of 55 asset managers. All 55 are in the interactive database (link above).

Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on…

Official resultOTHERReported outcome: Approved

Meeting held August 5, 2025.

Combines 4 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 130,474,503AGAINST: 155,613
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: To approve our payment of cash and equity-based compensation to non-employee directors for service on the Board of Directors and its committees, in the manner and on the basis set forth under "Proposal 3: Non-Employee Directors' Compensation" in the proxy statement.

Wave Life Sciences Ltd.’s own tally for this item (“3. The Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy”): 130,474,503 for, 155,613 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 - Shareholders approved the Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follow…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 28,078,642 for.

FOR
FOR: 28,078,642
Largest asset managers voting on “To approve our payment of cash and equity-based compensation to non-employee directors for service on the Boar” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street296,4590 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For
John Hancock67,5490 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

The amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the…

Official resultOTHERReported outcome: Approved

Meeting held August 5, 2025.

Combines 3 wordings of this item as funds reported it.

81% Approved · of votes cast

FOR 81%AGAINST
FOR: 105,936,049AGAINST: 24,647,485

Prior year: 87.1% for (August 6, 2024 meeting) ▼ 6.0 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement.

Wave Life Sciences Ltd.’s own tally for this item (“4. The amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast”): 105,936,049 for, 24,647,485 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 - Shareholders approved the amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Wave Life Sciences Ltd.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (3 managers, 396,729 against).

The 56 asset managers below reported 26,927,881 for, 727,825 against, 6,157 abstained.

FOR
FOR: 26,927,881AGAINST: 727,825ABSTAIN: 6,157
Largest asset managers voting on “To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis ” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,393,1547,841 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse415,14433,138 00Mixed
State Street296,4590 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST0186,213 00Against
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica0110,769 00Against
Delaware/Macquarie081,955 00Against
Lincoln Financial73,5000 00For
John Hancock28,86838,681 00Mixed
GuideStone066,693 00Against

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

On a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Meeting held August 5, 2025.

Combines 5 wordings of this item as funds reported it.

99.3% Approved · of votes cast

FOR 99.3%
FOR: 129,648,036AGAINST: 977,466

Prior year: 99.6% for (August 6, 2024 meeting) ▼ 0.4 pts

Details: description as filed, official tally, votes by 191 asset managers

Description as filed by funds: To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement

Wave Life Sciences Ltd.’s own tally for this item (“6. On a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast”): 129,648,036 for, 977,466 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 6 - Shareholders approved on a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast as follows:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 55 asset managers voting on “To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in t” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street296,4590 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For
John Hancock67,5490 00For

Fund voting reports, all 55 managers: 28,009,679 for, 12,891 against, 18,157 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 152 asset managers voting on “To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in t” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
RA CAPITAL MANAGEMENT, L.P.18,202,0090 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.14,462,3840 00For
MAVERICK CAPITAL LTD6,541,9670 00For
M28 Capital Management LP5,664,5480 00For
PRIMECAP MANAGEMENT CO/CA/4,957,0000 00For
T. Rowe Price4,917,6680 00For
BlackRock4,727,3029,277 00For
DRIEHAUS CAPITAL MANAGEMENT LLC4,352,8860 00For
683 Capital Management, LLC3,425,3350 00For
Loomis Sayles3,250,2180 00For
Siren, L.L.C.3,155,2270 00For
GEODE CAPITAL MANAGEMENT, LLC2,615,9260 00For
State Street2,264,331294 00For
Artisan2,055,5360 00For
Charles Schwab2,033,2380 00For
Polar Capital Holdings Plc2,007,0000 00For
EMERALD MUTUAL FUND ADVISERS TRUST1,937,0660 00For
EMERALD ADVISERS, LLC1,773,5030 00For
MPM BioImpact LLC1,505,2620 00For
Kynam Capital Management, LP1,305,3560 00For
Affinity Asset Advisors, LLC1,123,1000 00For
RTW INVESTMENTS, LP900,0000 00For
Northern Trust767,5920 00For
PLATINUM INVESTMENT MANAGEMENT LTD657,4860 00For
Fidelity516,9300 00For

Institutional-manager reports, all 152 managers: 101,136,601 for, 296,114 against, 940 not voted, 42,048 1 year. Showing the 25 largest; every one is in the interactive database (link above).

To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Meeting held August 5, 2025.

Combines 4 wordings of this item as funds reported it.

100% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 190 asset managers

Description as filed by funds: TO APPROVE, ON A NON-BINDING, ADVISORY BASIS ONLY, THE FREQUENCY OF HOLDING FUTURE SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 54 asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS ONLY, THE FREQUENCY OF HOLDING FUTURE SHAREHOLDER ADVISORY VOTES ” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock00 00--
T. Rowe Price00 00--
Vanguard00 00--
Fidelity00 00--
PRIMECAP Odyssey Funds00 00--
Charles Schwab00 00--
Loomis Sayles00 00--
Principal00 00--
RBB FUND, INC.00 00--
DRIEHAUS MUTUAL FUNDS00 00--
Brighthouse448,2820 00For
State Street00 00--
Equitable00 00--
Global X00 00--
TIAA00 00--
Prudential/PGIM00 00--
OPTIMUM FUND TRUST00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
TRUST FOR PROFESSIONAL MANAGERS00 00--
Jackson National00 00--
AIG/SunAmerica00 00--
Delaware/Macquarie00 00--
Lincoln Financial00 00--
John Hancock00 00--
GuideStone00 00--

Fund voting reports, all 54 managers: 448,282 for, 6,157 abstained, 27,177,559 1 year, 12,000 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 150 asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS ONLY, THE FREQUENCY OF HOLDING FUTURE SHAREHOLDER ADVISORY VOTES ” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ADAGE CAPITAL PARTNERS GP, L.L.C.00 00--
RA CAPITAL MANAGEMENT, L.P.00 00--
MAVERICK CAPITAL LTD00 00--
M28 Capital Management LP00 00--
PRIMECAP MANAGEMENT CO/CA/00 00--
T. Rowe Price00 00--
BlackRock868,7540 00For
DRIEHAUS CAPITAL MANAGEMENT LLC00 00--
683 Capital Management, LLC00 00--
Loomis Sayles00 00--
Siren, L.L.C.00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
State Street00 00--
Artisan00 00--
Charles Schwab00 00--
Polar Capital Holdings Plc00 00--
EMERALD MUTUAL FUND ADVISERS TRUST00 00--
EMERALD ADVISERS, LLC00 00--
MPM BioImpact LLC00 00--
Kynam Capital Management, LP1,305,3560 00For
Affinity Asset Advisors, LLC00 00--
RTW INVESTMENTS, LP00 00--
Northern Trust00 00--
PLATINUM INVESTMENT MANAGEMENT LTD00 00--
Fidelity00 00--

Institutional-manager reports, all 150 managers: 2,251,912 for, 940 not voted, 93,582,822 1 year, 314,256 3 year, 15,000 unknown. Showing the 25 largest; every one is in the interactive database (link above).

The re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent…

Official resultOTHERReported outcome: Approved

Meeting held August 5, 2025.

Combines 2 wordings of this item as funds reported it.

99.6% Approved · of votes cast

FOR 99.6%
FOR: 144,541,282AGAINST: 619,542
Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided through the date of our 2026 Annual General Meeting of Shareholders.

Wave Life Sciences Ltd.’s own tally for this item (“2. The re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of t”): 144,541,282 for, 619,542 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Shareholders approved the re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuner…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 28,034,570 for, 6,157 abstained.

FOR
FOR: 28,034,570ABSTAIN: 6,157
Largest asset managers voting on “To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and in” at Wave Life Sciences Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,059,9450 00For
T. Rowe Price3,529,3950 00For
Vanguard3,171,5880 00For
Fidelity2,841,7000 00For
PRIMECAP Odyssey Funds2,378,3800 00For
Charles Schwab1,977,0320 00For
Loomis Sayles1,812,0310 00For
Principal1,400,9950 00For
RBB FUND, INC.1,329,1910 00For
DRIEHAUS MUTUAL FUNDS916,0230 00For
Brighthouse509,1010 00For
JPMorgan324,1420 00For
State Street296,4590 00For
Equitable250,5950 00For
Global X246,6590 00For
TIAA218,3710 00For
Prudential/PGIM197,3290 00For
OPTIMUM FUND TRUST186,2130 00For
QUANTITATIVE MASTER SERIES LLC181,5210 00For
TRUST FOR PROFESSIONAL MANAGERS172,7310 00For
Jackson National124,7760 00For
AIG/SunAmerica110,7690 00For
Lincoln Financial85,2680 00For
Delaware/Macquarie81,9550 00For
John Hancock67,5490 00For

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Largest Wave Life Sciences Ltd. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 155,673,292 shares outstanding at the time of that meeting.

Fund voting reports: top Wave Life Sciences Ltd. shareholders by shares voted on “To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a…”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 4.48%
2T. Rowe Price 4.01%
3Fidelity 3.90%
4Federated Hermes 2.54%
5PRIMECAP Odyssey Funds 2.47%
6Vanguard 1.80%
7Charles Schwab 0.76%
8DRIEHAUS MUTUAL FUNDS 0.61%
9State Street 0.42%
10RBB FUND, INC. 0.37%
Institutional-manager reports: top Wave Life Sciences Ltd. shareholders by shares voted on “To approve, by a non-binding advisory vote, the compensation of our named executive officers as…”, 2025-2026
#Asset manager % of shares outstanding
1RA CAPITAL MANAGEMENT, L.P. 11.69%
2ADAGE CAPITAL PARTNERS GP, L.L.C. 9.29%
3MAVERICK CAPITAL LTD 4.20%
4M28 Capital Management LP 3.64%
5PRIMECAP MANAGEMENT CO/CA/ 3.18%
6T. Rowe Price 3.16%
7BlackRock 3.04%
8DRIEHAUS CAPITAL MANAGEMENT LLC 2.80%
9683 Capital Management, LLC 2.20%
10Loomis Sayles 2.09%

Reported Wave Life Sciences Ltd. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Wave Life Sciences Ltd. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
RA Capital Management, L.P.34,314,406 22.04%Schedule 13D, filed August 11, 2026
BlackRock14,117,412 9.07%Form 13F, quarter ended March 31, 2026
T. Rowe Price8,704,550 5.59%Form 13F, quarter ended March 31, 2026
FMR (Fidelity)5,192,761 3.34%Form 13F, quarter ended March 31, 2026
State Street3,674,033 2.36%Form 13F, quarter ended March 31, 2026
Geode Capital3,579,099 2.30%Form 13F, quarter ended March 31, 2026
Vanguard Group3,573,746 2.30%Form 13F, quarter ended March 31, 2026
Citadel Advisors2,818,156 1.81%Form 13F, quarter ended March 31, 2026
Two Sigma1,878,115 1.21%Form 13F, quarter ended March 31, 2026
Goldman Sachs1,383,590 0.89%Form 13F, quarter ended March 31, 2026

Percentages above are of 155,673,292 shares outstanding, as reported by Wave Life Sciences Ltd. on its Form 10-Q dated June 30, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Wave Life Sciences Ltd.'s 2 shareholder meetings in the 2025-2026 proxy season (held August 5, 2025 and June 22, 2026), 198 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 3,417 separate fund positions. Their filings are grouped here into 16 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held August 5, 2025 — To approve, by a non-binding advisory vote, the compensation of our named executive officers as… — Wave Life Sciences Ltd.'s filing reports the proposal as approved, with 99.3% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Wave Life Sciences Ltd.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on August 11, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Wave Life Sciences Ltd.’s 10-Q dated June 30, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Wave Life Sciences Ltd. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Wave Life Sciences (WVE) 2025-2026 Annual & Special Meetings”, https://proxyvotesnow.com/company/wave-life-sciences-ltd/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.